Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-12041596

RESUMEN

The precise occurrence of Opisthochis viverrini infection in humans, who were positive for Opisthorchis-like eggs in a stool examination, was determined using the potassium permanganate staining method. In the 68 specimens examined, there were more individual O. viverrini eggs (38.24%) than singular Haplorchis taichui eggs (29.41%). One-fourth of the total specimens contained a mixed infection of O. viverrini and H. taichi eggs. The median ratio of O. viverrini: H. taichui eggs in mixed infection cases was 2.29 (min = 1, max = 17.5). It is suggested that chemotherapy with praziquentel treatment should be given to patients who are positive for O. viverrini-like eggs.


Asunto(s)
Heces/parasitología , Opistorquiasis/epidemiología , Animales , Antihelmínticos/uso terapéutico , Colorantes , Diagnóstico Diferencial , Heterophyidae/efectos de los fármacos , Heterophyidae/crecimiento & desarrollo , Humanos , Opistorquiasis/complicaciones , Opistorquiasis/diagnóstico , Opistorquiasis/tratamiento farmacológico , Opisthorchis/efectos de los fármacos , Opisthorchis/crecimiento & desarrollo , Recuento de Huevos de Parásitos , Permanganato de Potasio , Praziquantel/uso terapéutico , Prevalencia , Tailandia/epidemiología , Infecciones por Trematodos/complicaciones , Infecciones por Trematodos/diagnóstico , Infecciones por Trematodos/tratamiento farmacológico , Infecciones por Trematodos/epidemiología
2.
Artículo en Inglés | MEDLINE | ID: mdl-9886106

RESUMEN

The study was carried out from September to November 1997 in Phrae Province of northern Thailand. A total of 95 adult patients with Opisthorchis-like ova in their stools were randomly treated with two different manufactured Praziquantels. Group 1, consisting of 49 patients, received a single dose of 40 mg per kg Praziquantel manufactured by the Thai Government Pharmaceutical Organization. Group 2 (46 patients) received Biltricide at the same dosage. Haplorchis taichui, H. yokogawai, Echinostome spp., O. viverrini, Taenia saginata and Enterobius vermicularis were expelled in the stools after treatment. Minute intestinal flukes were detected in 64% of patients. O. viverrini was found in lower proportion of 17%. By formalin-ether concentration examination one stool specimen from each patient, the cure rate in both groups on the 30th day of treatment was 100%. The side effects of the two different Praziquantel treatments were mild with no significant difference. Praziquantel, regardless of its manufacture, proved effective against O. viverrini and other minute intestinal flukes (H. taichui, H. yokogawai and Echinostome spp).


Asunto(s)
Antiplatelmínticos/uso terapéutico , Parasitosis Intestinales/tratamiento farmacológico , Opistorquiasis/tratamiento farmacológico , Opisthorchis/aislamiento & purificación , Praziquantel/uso terapéutico , Adolescente , Adulto , Anciano , Animales , Antiplatelmínticos/farmacología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Praziquantel/farmacología , Resultado del Tratamiento
3.
Am J Trop Med Hyg ; 56(3): 311-4, 1997 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9129534

RESUMEN

A community study on opisthorchiasis was conducted in Prachinburi Province in eastern Thailand during 1990-1992. The morbidity from opisthorchiasis in the community and reversibility of biliary pathology following treatment with praziquantel at a single dose of 40 mg/kg were assessed by longitudinal investigations of clinical, laboratory, and ultrasonographic changes. A total of 913 voluntary subjects infected with Opisthorchis viverrini were randomly selected for longitudinal study, and 579 subjects without liver fluke infection were recruited as controls. The majority of the study group suffered from mild and moderate infections that were associated with nonspecific gastrointestinal symptoms. Grade I and II ultrasonographic changes, which indicated chronic inflammation of the biliary tract and gallbladder, were detected in 32% of the infected individuals. Clinical symptoms and ultrasonographic changes were common in subjects 21-40 years of age and older. Satisfactory resolution of morbidity was observed during two years follow-up on days 0, 60, 180, 360, and 720, as shown by significant clinical improvement, normalization of laboratory parameters, and downgrading of ultrasonographic abnormalities. Portable ultrasonography has proved to be a reliable noninvasive technique in the evaluation of the morbidity due to opisthorchiasis in rural areas.


Asunto(s)
Antiplatelmínticos/uso terapéutico , Opistorquiasis/tratamiento farmacológico , Opistorquiasis/epidemiología , Praziquantel/uso terapéutico , Adolescente , Adulto , Sistema Biliar/diagnóstico por imagen , Niño , Preescolar , Heces/parasitología , Femenino , Estudios de Seguimiento , Hepatomegalia , Humanos , Hígado/diagnóstico por imagen , Estudios Longitudinales , Masculino , Morbilidad , Opistorquiasis/diagnóstico por imagen , Recuento de Huevos de Parásitos , Tailandia/epidemiología , Ultrasonografía
4.
Artículo en Inglés | MEDLINE | ID: mdl-9656393

RESUMEN

Plasmodium falciparum in Southeast Asia is highly resistant to chloroquine, sulfadoxine/ pyrimethamine, quinine and even mefloquine. The use of two doses of short course artemether/mefloquine combination has been shown to be effective in a recent study. In the present study, we have assessed the efficacy of short course treatment with artesunate/mefloquine, in comparison with artemether/mefloquine in patients with multidrug resistant falciparum malaria. Ninety-nine Thai male patients who sought consultation at Makham Malaria Clinic, Chantaburi (eastern part of Thailand), were randomized to receive either the combination of artemether (150 and 100 mg; group A) or artesunate (150 and 100 mg; group B) with mefloquine (750 and 500 mg) at 24 hours apart. The follow-up was on days 1, 2, 7, 14, 21, 28, 35 and 42. Patients in both groups showed a rapid initial response to treatment; fever and parasite were cleared within 48 hours in 100 and 100% vs 91.8 and 96%, for group A vs B, respectively. All patients in group A had completed the 42 day-follow up; however, two patients in group B did not finish the 42-day follow-up. The cure rate was 100% in either group. No serious adverse effects were found. Artemether or artesunate with mefloquine given two doses at 24 hours apart can be used as effective alternative treatment regimens for multidrug resistant falciparum malaria.


Asunto(s)
Antimaláricos/administración & dosificación , Artemisininas , Malaria Falciparum/tratamiento farmacológico , Mefloquina/administración & dosificación , Sesquiterpenos/administración & dosificación , Enfermedad Aguda , Adulto , Arteméter , Artesunato , Esquema de Medicación , Resistencia a Medicamentos , Quimioterapia Combinada , Humanos , Masculino , Persona de Mediana Edad , Tailandia , Resultado del Tratamiento
6.
Trans R Soc Trop Med Hyg ; 90(4): 415-7, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8882193

RESUMEN

Plasmodium falciparum in south-east Asia is highly resistant to chloroquine and sulfadoxine-pyrimethamine. Mefloquine used to be the chemosuppressant drug of choice in areas with chloroquine resistance. However, sensitivity to this drug has recently decreased in Thailand, Cambodia and Myanmar, and there is no suitable single alternative drug. We therefore investigated possible alternative combination therapies for multidrug resistant falciparum malaria. 120 male Thai patients at Makarm Malaria Clinic, Chantaburi, in eastern Thailand were allocated at random to receive either oral artemether (group A) or artesunate (group B) at a single dose of 300 mg on day 1, both followed by mefloquine, 750 and 500 mg at 24 and 30 h, respectively. Follow-up was on days 1, 2, 7, 14, 21, 28, 35 and 42. Patients in both groups had a rapid initial response to treatment; in most cases parasitaemia was cleared within 24 h, and fever was cleared within 24 h in 62% and 76.7% of the patients in groups A and B, respectively. 58 patients in group A and 57 in group B completed follow-up and cure rates were 98% and 97%, respectively. Reinfection could not be excluded for the 3 patients with recrudescences; all were cured with a repeated course of treatment. No serious adverse effect was observed in either group, only mild and transient nausea, vomiting and loss of appetite, with no significant difference between the 2 groups. These results suggest that a single oral dose of 300 mg of either artemether or artesunate followed by 1250 mg of mefloquine in 2 divided doses is effective against multiple drug resistant falciparum malaria. Either regimen can be considered as a suitable 'stand-by' in endemic areas of multiple drug resistant falciparum malaria.


Asunto(s)
Antimaláricos/uso terapéutico , Artemisininas , Malaria Falciparum/tratamiento farmacológico , Mefloquina/uso terapéutico , Sesquiterpenos/uso terapéutico , Adolescente , Adulto , Antimaláricos/efectos adversos , Arteméter , Artesunato , Resistencia a Múltiples Medicamentos , Quimioterapia Combinada , Humanos , Masculino , Mefloquina/efectos adversos , Persona de Mediana Edad , Distribución Aleatoria , Recurrencia , Sesquiterpenos/efectos adversos , Tailandia
7.
Int J Parasitol ; 25(8): 971-3, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8550296

RESUMEN

We evaluated an enzyme-linked immunosorbent assay using crude parasite homogenates as a diagnostic test for Opisthorchis viverrini infection in humans. Serum antibody (Ab) responses to O. viverrini adult worm homogenate (AWH) and metacercaria homogenate (MH) were studied in 83 infected residents of an opisthorchiasis-endemic area in Thailand. Elevated levels of Ab persisted for over 1 year following curative treatment with praziquantel, and cross-reactivity to O. viverrini AWH and MH antigens was observed in sera from individuals with other parasitic infections. Serum Ab to crude AWH and MH are therefore unsuitable for immunodiagnosis since they may be non-specific and would not differentiate between ongoing and past infection.


Asunto(s)
Anticuerpos Antihelmínticos/sangre , Opistorquiasis/diagnóstico , Opisthorchis , Animales , Formación de Anticuerpos , Especificidad de Anticuerpos , Antiplatelmínticos/uso terapéutico , Reacciones Cruzadas , Ensayo de Inmunoadsorción Enzimática/métodos , Estudios de Seguimiento , Humanos , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Opistorquiasis/tratamiento farmacológico , Opistorquiasis/inmunología , Opisthorchis/inmunología , Praziquantel/uso terapéutico , Tailandia , Factores de Tiempo
8.
Trans R Soc Trop Med Hyg ; 89(2): 213-5, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-7778152

RESUMEN

Plasmodium falciparum in Thailand is highly resistant to chloroquine and sulfadoxine/pyrimethamine and there is increasing resistance to the alternative antimalarials, quinine and mefloquine. In eastern Thailand, the cure rates of mefloquine at 750 and 1250 mg were 30% and 55%, respectively. The use of drug combinations may be necessary in areas where drug-resistant parasites exist. 159 male Thai patients in Chantaburi, eastern Thailand, were allocated at random to receive either oral artemether at a single dose of 300 mg on the first day followed by mefloquine 750 mg at 24 h and 500 mg at 30 h (group A), or oral artemether at a single dose of 300 mg on the first day, mefloquine 750 mg at 24 h and placebo at 30 h (group B). The follow-up was on days 1, 2, 7, 14, 21, 28, 35 and 42. Most patients in both groups had a rapid initial response to treatment, parasitaemia being cleared within 24 h and fever cleared within 48 h in both groups. The cure rates were 97% and 90%, respectively, for groups A and B. No serious adverse effect was seen in either group; mild and transient nausea, vomiting and loss of appetite were noted. The adverse effects did not differ between the 2 groups. The results suggested that a single oral dose of artemether (300 mg) can markedly improve the cure rate of mefloquine at a dose of 750 or 1250 mg in multiple drug-resistant falciparum malaria.


Asunto(s)
Antimaláricos/uso terapéutico , Artemisininas , Resistencia a Múltiples Medicamentos , Malaria Falciparum/tratamiento farmacológico , Mefloquina/uso terapéutico , Sesquiterpenos/uso terapéutico , Adolescente , Adulto , Arteméter , Método Doble Ciego , Quimioterapia Combinada , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
10.
Trans R Soc Trop Med Hyg ; 88(5): 561-4, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7992340

RESUMEN

A population-based study of the clinical, laboratory and ultrasonographic findings in patients suffering from mild or moderate opisthorchiasis in Prachinburi province, Thailand was conducted in 1990-1992. The effectiveness of treatment with praziquantel at 40 mg/kg body weight was evaluated. After treatment, a long-lasting, marked improvement in the well-being of the study group was observed. Symptoms common in opisthorchiasis infection decreased in intensity and the clinical response showed total or partial remission in 98% of all cases studied. Total and direct bilirubin concentrations decreased significantly and remained low up to the end of the follow-up period of 2 years, indicating a reduction in cholestasis. Also, white blood cell counts decreased initially, which can be interpreted as a reduction in inflammation intensity. No relationship was found between intensity of infection and age or clinical findings. Population-based treatment of opisthorchiasis appears to have had a significant impact on public health in north-east Thailand. However, it is also evident that drug therapy alone will not solve the opisthorchiasis problem, as indicated by the reinfection rate of almost 10% at the end of the study.


Asunto(s)
Opistorquiasis/diagnóstico por imagen , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Bilirrubina/sangre , Femenino , Humanos , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Opistorquiasis/sangre , Opistorquiasis/tratamiento farmacológico , Praziquantel/uso terapéutico , Tailandia , Resultado del Tratamiento , Ultrasonografía
11.
Trans R Soc Trop Med Hyg ; 88(4): 471-4, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7570848

RESUMEN

The liver flukes Opisthorchis viverrini and Clonorchis sinensis chronically infect over 30 million people in south-eastern Asia, resulting in significant morbidity and a predisposition to cholangiocarcinoma (CCA). Liver fluke-associated CCA carries a poor prognosis, partly because it is often detected at a late and advanced stage. The development of improved diagnostic methods, particularly for early CCA, may improve chances of survival and cure. Accordingly, we explored the use of immunological responses to liver fluke antigens as a potential means of identifying individuals at high risk for liver fluke-associated CCA. Serum antibody responses to O. viverrini adult worm homogenate and metacercaria homogenate (MH) were studied using enzyme-linked immunosorbent and immunoblot assays in 65 infected residents of an opisthorchiasis-endemic area in Thailand. Antibody levels correlated with liver ultrasonography (U/S) findings, and immunoblot analysis revealed a 91/93 kDa MH doublet recognized only by sera of individuals with severe liver U/S findings, including CCA. These results suggest that serum antibody responses to liver fluke antigens may be useful in the identification of infected individuals who are at high risk for liver fluke-associated CCA.


Asunto(s)
Anticuerpos Antihelmínticos/sangre , Neoplasias de los Conductos Biliares/sangre , Conductos Biliares Intrahepáticos , Biomarcadores de Tumor/sangre , Colangiocarcinoma/sangre , Opistorquiasis/sangre , Opisthorchis/inmunología , Animales , Antígenos Helmínticos/inmunología , Neoplasias de los Conductos Biliares/parasitología , Colangiocarcinoma/parasitología , Ensayo de Inmunoadsorción Enzimática , Humanos , Immunoblotting
12.
Parasite Immunol ; 16(6): 279-88, 1994 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7526321

RESUMEN

Chronic infections with the liver flukes Opisthorchis viverrini and Clonorchis sinensis affect over 30 million people in southeastern Asia. With ongoing exposure, reinfection readily occurs following curative treatment and cumulative infections result in significant morbidity and a predisposition to cholangiocarcinoma. Though protective immunity has never been described in human opisthorchiasis, heterogeneity in worm burden occurs and a small number of exposed residents of endemic areas remain apparently uninfected. To explore the nature of this heterogeneity, we compared levels of serum antibody (Ab) to O. viverrini measured by an enzyme-linked immunosorbent assay in 83 stool egg-positive and 49 stool egg-negative residents of an O. viverrini-endemic area in Thailand. Compared to the egg-positive residents, the egg-negative group had significantly higher levels of immunoglobulin (Ig)G, IgA and IgM to adult worm homogenate (AWH) and total Ab to metacercaria homogenate (MH). Furthermore, immunoblot analyses revealed that a significantly higher proportion of sera from the egg-negative residents had IgA reactivity against a 38-kDa AWH antigen and IgM reactivity against carbohydrate epitopes of a 42-kDa AWH glycoprotein antigen. These findings support a hypothesis that the egg-negative group includes individuals who may be immunologically resistant to this usually chronic infection.


Asunto(s)
Anticuerpos Antihelmínticos/análisis , Opistorquiasis/inmunología , Opisthorchis/inmunología , Adolescente , Adulto , Animales , Antígenos Helmínticos/inmunología , Niño , Preescolar , Ensayo de Inmunoadsorción Enzimática , Epítopos/inmunología , Heces/parasitología , Glicoproteínas/inmunología , Humanos , Inmunidad Innata , Inmunoglobulinas/análisis , Opisthorchis/aislamiento & purificación , Recuento de Huevos de Parásitos , Tailandia
13.
Artículo en Inglés | MEDLINE | ID: mdl-7939947

RESUMEN

The pharmacokinetics of praziquantel was investigated in 9 Thai male patients with asymptomatic opisthorchiasis (stool positive) and 9 patients (6 males, 3 females) with moderately advanced infection (hepatomegaly). The geometric means of the pretreatment Opisthorchis viverrini egg count in these patients were 2,950 vs 4,468 eggs per gram of stool. The results indicate the impairment of metabolism of praziquantel in the moderately advanced stage opisthorchiasis. The pharmacokinetics of the drug in these patients during the acute infection was markedly altered when compared with that after recovery and in patients with early stage of the infection. The clearance rate (Cl/f) was significantly reduced [medians and ranges of 106 (43-242) vs 192 (112-692) and 171 (133-427) ml/min/kg] and the t1/2z and MRT were prolonged [t1/2z: 3.8 (2.0-6.2) vs 2.7 (1.7-4.3) and 2.3 (1.7-2.8) hours; MRT: 6.2 (3.2-11.0) vs 4.6 (2.7-6.2) and 4.5 (2.9-5.1) hours]. In addition, AUCo-alpha was significantly greater [6.0 (2.5-15.6) vs 3.5 (0.6-6.0) and 3.9 (1.6-5.0) micrograms hour/ml].


Asunto(s)
Hígado/metabolismo , Opistorquiasis/tratamiento farmacológico , Praziquantel/farmacocinética , Praziquantel/uso terapéutico , Adulto , Femenino , Humanos , Pruebas de Función Hepática , Masculino , Tasa de Depuración Metabólica , Persona de Mediana Edad , Opistorquiasis/metabolismo , Opistorquiasis/parasitología , Recuento de Huevos de Parásitos
14.
Infect Dis Clin North Am ; 7(3): 699-716, 1993 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8254167

RESUMEN

The parasitic diseases of the liver and lung are caused by trematodes or flukes--Opisthorchis viverrini, O. felineus, Fasciola hepatica, and Paragonimus westermani. Humans get infected by eating the second intermediate host of the fluke, for example, fish, crab, or water plant. The disease runs a chronic course. The diagnosis is made by the recover of eggs in stools or sputum, or by serodiagnosis. Praziquantel is the drug of choice except in falcioliaisis.


Asunto(s)
Clonorquiasis , Fascioliasis , Opistorquiasis , Adulto , Animales , Antihelmínticos/uso terapéutico , Bencimidazoles/uso terapéutico , Clonorquiasis/diagnóstico por imagen , Clonorquiasis/tratamiento farmacológico , Clonorquiasis/parasitología , Fascioliasis/diagnóstico , Fascioliasis/tratamiento farmacológico , Fascioliasis/parasitología , Humanos , Hígado/diagnóstico por imagen , Opistorquiasis/diagnóstico por imagen , Opistorquiasis/tratamiento farmacológico , Opistorquiasis/epidemiología , Opistorquiasis/parasitología , Paragonimiasis/diagnóstico , Paragonimiasis/tratamiento farmacológico , Paragonimiasis/epidemiología , Paragonimiasis/parasitología , Praziquantel/uso terapéutico , Trematodos/crecimiento & desarrollo , Triclabendazol , Ultrasonografía
15.
J Parasitol ; 78(4): 672-80, 1992 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1635026

RESUMEN

Detailed studies of liver fluke proteins and antigens are necessary to facilitate further investigation of the human immune responses to these parasites. Accordingly, Opisthorchis viverrini antigens were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting. We initially encountered excessive background smearing, vertical streaking, and indistinct bands that were similar to problems previously described by investigators studying this and other trematodes including Schistosoma mansoni. These problems were especially evident with silver staining of proteins and occurred despite the extensive use of protease inhibitors. They were minimized by using mini (vs. large) SDS-PAGE and Coomassie blue protein staining. With the latter 2 techniques, adult worm somatic proteins and excretory-secretory products were separated and characterized. Immunoblots using rabbit anti-adult worm sera demonstrated that some of these proteins were antigens common to both the adult and metacercarial stages. Several of these antigens also corresponded (according to molecular weight) to glycoproteins, detected by concanavalin A blotting. These findings form a base for subsequent studies of the human immune response to liver fluke infection.


Asunto(s)
Antígenos Helmínticos/análisis , Glicoproteínas/análisis , Proteínas del Helminto/análisis , Opistorquiasis/parasitología , Opisthorchis/química , Animales , Antígenos Helmínticos/química , Antígenos Helmínticos/aislamiento & purificación , Cricetinae , Electroforesis en Gel de Poliacrilamida , Heces/parasitología , Glicoproteínas/química , Glicoproteínas/aislamiento & purificación , Proteínas del Helminto/química , Proteínas del Helminto/aislamiento & purificación , Humanos , Immunoblotting , Hígado/parasitología , Peso Molecular , Opistorquiasis/tratamiento farmacológico , Opisthorchis/inmunología , Praziquantel/uso terapéutico , Colorantes de Rosanilina , Tinción con Nitrato de Plata
16.
Int J Parasitol ; 22(4): 527-31, 1992 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1644529

RESUMEN

Detection of Opisthorchis viverrini antigens in stools using specific monoclonal antibody. International Journal for Parasitology 22: 527-531. A sandwich enzyme-linked immunosorbent assay (ELISA) was developed for detecting Opisthorchis viverrini antigen in faecal extracts of four groups of individuals. These were 24 patients with O. viverrini infection only (group 1), 31 patients with O. viverrini and other parasitic infections (group 2), 141 patients with other parasitic infections (group 3) and 21 normal, parasite-free individuals (group 4). The first antibody used in the ELISA was polyclonal immunoglobulin G prepared from the serum of a rabbit previously immunized with crude extract of O. viverrini. The second antibody was monoclonal antibody specific to an antigen located in the worm tegument and muscular tissue. Sensitivity of the assay was 31% while specificity was 100%. Considerations for improving the sensitivity are discussed.


Asunto(s)
Anticuerpos Monoclonales , Antígenos Helmínticos/análisis , Heces/parasitología , Opistorquiasis/diagnóstico , Opisthorchis/inmunología , Animales , Ensayo de Inmunoadsorción Enzimática , Humanos , Sensibilidad y Especificidad
17.
Int J Parasitol ; 21(8): 969-74, 1991 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1787041

RESUMEN

A Balb/c mouse was immunized with a crude soluble antigen of Opisthorchis viverrini adult worms (OVAA) over a period of 7 months. Spleen cells from the immune mouse were fused with Sp2/0 myeloma cells. Among the 264 tissue culture wells containing the fused cells, cells of 96 wells (36%) produced antibodies to the immunizing agent. Antibodies produced by cells in several wells reacted with antigens from other species of parasite. Cells of 17 wells produced antibodies specific only to OVAA, thus cells from three representative wells were cloned by limiting dilution. Hybrids obtained produced antibodies which could be classified according to their tissue specificities into three groups. The first group of antibodies reacted strongly to the worm integument and weakly with the muscles while those belonging to the second group reacted only to muscles of the worms. The monoclonal antibodies of the third group gave a positive reaction to both muscles and tegument.


Asunto(s)
Anticuerpos Monoclonales/biosíntesis , Opisthorchis/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Especificidad de Anticuerpos , Hibridomas , Ratones , Ratones Endogámicos BALB C
18.
Trans R Soc Trop Med Hyg ; 85(2): 277-9, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1653472

RESUMEN

Opisthorchiasis is a major public health problem in north-east Thailand, where over 7 million inhabitants are reported to be infected. A significant percentage of infected individuals develops cholangiocarcinoma terminally, which is rapidly fatal. To determine whether certain tumour markers are elevated in Thai patients with cholangiocarcinoma, and thus might be useful in the diagnosis of cholangiocarcinoma associated with opisthorchiasis in Thailand, the tumour markers CA125 and CA19-9 were measured by radioimmunoassay in 94 serum samples. The subjects consisted of 52 patients admitted for non-gastroenterological diseases, 7 patients with histologically proven cholangiocarcinoma, 7 patients with clinically suspected cholangiocarcinoma, and 28 patients with uncomplicated opisthorchiasis. The mean levels (+/- standard deviation [SD]) of CA19-9 and CA125 in the controls were 12.5 +/- 10.2 and 24.7 +/- 11.1 units/ml respectively. Using the mean + 3SD as the cut-off level, 57.1% of patients with confirmed cholangiocarcinoma had elevated CA19-9 and 28.6% had elevated CA125. In patients with clinically suspected cholangiocarcinoma, 71.4% had elevated CA19-9 and 28.6% had elevated CA125. Among opisthorchiasis patients, 3.6% had elevated CA125 and none had elevated CA19-9. 1.9% of controls had elevated CA19-9 and none had elevated CA125. When positivity of either CA125 or CA19-9 was used as an indicator of malignancy, the sensitivity and specificity of the combined tests reached 85.7% and 98.1% respectively. These preliminary results suggest that the measurement of CA125 and CA19-9 may be useful in the early detection of opisthorchiasis-associated cholangiocarcinoma.


Asunto(s)
Adenoma de los Conductos Biliares/diagnóstico , Antígenos de Carbohidratos Asociados a Tumores/sangre , Neoplasias de los Conductos Biliares/diagnóstico , Opistorquiasis/diagnóstico , Adenoma de los Conductos Biliares/complicaciones , Adolescente , Adulto , Anciano , Neoplasias de los Conductos Biliares/complicaciones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Opistorquiasis/complicaciones
19.
Artículo en Inglés | MEDLINE | ID: mdl-2237595

RESUMEN

A study of the relation of fecal egg excretion to worm burden and clinical features was carried out in 45 opisthorchiasis patients who had no signs of biliary obstruction. The fecal egg excretion was consistent and correlated with the worm burden. Although there was no definite association between clinical signs and intensity of infection, mild hepatomegaly and thickened wall or dilatation of the gallbladder were found more commonly in heavily infected patients. Eosinophilia was observed more often than previous reports. Concomitant parasitic infections were found in 82% of the patients. After praziquantel treatment, egg counts increased greatly during the first few days then decreased to very low levels in 7 days.


Asunto(s)
Heces/parasitología , Opistorquiasis/parasitología , Adolescente , Adulto , Anciano , Eosinófilos/química , Femenino , Humanos , Pruebas de Función Hepática , Masculino , Persona de Mediana Edad , Opistorquiasis/sangre , Opistorquiasis/fisiopatología , Recuento de Huevos de Parásitos
20.
Artículo en Inglés | MEDLINE | ID: mdl-2772709

RESUMEN

The pathology of human opisthorchiasis in 22 adults (20 to 68 years) and 7 children (7 to 15 years) at autopsy is described. The changes of the liver in adults and children are similar and are summarized as follows: Enlargement of the liver was a common finding. Pericholangitis was observed in most cases. The pathology was confined to the large and medium-sized bile ducts where the flukes inhabited. The small interlobular bile ducts had minimal or unremarkable changes. Dilatation of the bile ducts with hyperplasia, desquamation and proliferation of the bile duct epithelial cells, glandular formation and fibrous connective tissue infiltration of the walls were the most common features. The pathological changes were well established within 7 to 15 years. Dilatation of the gallbladder, chronic cholecystitis and carcinoma were found only in adults. Eight of ten cases were cholangiocarcinoma and two were hepatocellular carcinoma.


Asunto(s)
Envejecimiento/patología , Opistorquiasis/patología , Adolescente , Adulto , Anciano , Niño , Vesícula Biliar/parasitología , Vesícula Biliar/patología , Humanos , Hígado/parasitología , Hígado/patología , Neoplasias Hepáticas/patología , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA